|
|
EQSNews: BRAIN Biotech AG
/ Key words: Miscellaneous
BRAIN Biotech AG takes next step to optimize group structure
16.04.2024 / 11:20 CET/CEST
The issuer is solely responsible for the content of this announcement.
BRAIN Biotech AG takes next step to optimize group structure... Lire le communiqué |
|
| |
|
| |
|
|
EQSNews: BRAIN Biotech AG
/ Key words: Alliance/Sustainability
Beverages made from vine leaves: Sustainable drinking pleasure based on agricultural side streams
14.03.2024 / 09:00 CET/CEST
The issuer is solely responsible for the content of this announcement.
Beverages made from vine leaves: S... Lire le communiqué |
|
| |
|
| |
|
|
EQSNews: BRAIN Biotech AG
/ Key words: AGM/EGM
Results of the Annual General Meeting 2024 for the financial year 2022/23 of BRAIN Biotech AG
12.03.2024 / 17:17 CET/CEST
The issuer is solely responsible for the content of this announcement.
Results of the Annual General Meeting 2024 for the fin... Lire le communiqué |
|
| |
|
| |
|
|
EQSNews: BRAIN Biotech AG
/ Key words: Alliance/Sustainability
Collaboration between BRAIN Biotech and AMSilk: Protein engineering successfully improves structural proteins for performance materials
05.03.2024 / 08:00 CET/CEST
The issuer is solely responsible for the content of this announcement.... Lire le communiqué |
|
| |
|
| |
|
|
EQSNews: BRAIN Biotech AG
/ Key words: Bond
BRAIN Biotech AG successfully placed EUR 5.0 million convertible bond for the financing of further growth initiatives
29.02.2024 / 20:40 CET/CEST
The issuer is solely responsible for the content of this announcement.
BRAIN Biotech AG successfully pla... Lire le communiqué |
|
| |
|
| |
|
|
EQSAdhoc: BRAIN Biotech AG / Key words: Bond
BRAIN Biotech AG: Issuance of EUR 5 million convertible bond with exclusion of subscription rights
29Feb2024 / 20:06 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation EU No 596/2014, transmitted by EQS News a service of EQS Group AG.
The issuer is solely responsible for the con... Lire le communiqué |
|
| |
|
| |
|
|
EQSNews: BRAIN Biotech AG
/ Key words: Quarterly / Interim Statement
3M FY 23/24: BRAIN Biotech looks optimistic to stay on the growth path for fiscal year 2023/24
28.02.2024 / 07:30 CET/CEST
The issuer is solely responsible for the content of this announcement.
3M FY 23/24: BRAIN... Lire le communiqué |
|
| |
|
| |
